DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients

Angelo Karaboyas; Hairong Xu; Hal Morgenstern; Francesco Locatelli; Michel Jadoul; Kosaku Nitta; Indranil Dasgupta; Francesca Tentori; Friedrich K. Port; Bruce M. Robinson

doi:https://doi.org/10.1016/j.kint.2018.03.013

DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients

Identifier:nobleid.org/w1/20260421/A471AEB8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A471AEB8.svg?ark=w1%2F20260421%2FA471AEB8)](https://nobleid.org/work/w1/20260421/A471AEB8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients

Identifier:nobleid.org/w1/20260421/A471AEB8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A471AEB8.svg?ark=w1%2F20260421%2FA471AEB8)](https://nobleid.org/work/w1/20260421/A471AEB8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work